Completed NA INTERVENTIONAL 2-arm NCT00594607

Effect of Nephral 400 ST Dialysis Membrane on Coagulation in Hemodialysis

A Comparing Study of Nephral 400 ST and Fx8 Dialysis Membranes on Coagulation During Hemodialysis

Sponsor: Rikshospitalet University Hospital

Conditions Extracorporeal Clotting During Hemodialysis

Interventions AN69ST dialysis membrane Fx8 (Fresenius)

Updated 5 times since 2017 Last updated: Jul 3, 2011 Started: Sep 30, 2004 Primary completion: May 31, 2008 Completion: May 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Extracorporeal Clotting During Hemodialysis, this trial is completed. The trial is conducted by Rikshospitalet University Hospital and has accumulated 5 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rikshospitalet University Hospital
Ullevaal University Hospital

Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway